Purine Nucleotide Availability Regulates mTORC1 Activity through the Rheb GTPase
Pharmacologic agents that interfere with nucleotide metabolism constitute an important class of anticancer agents. Recent studies have demonstrated that mTOR complex 1 (mTORC1) inhibitors suppress de novo biosynthesis of pyrimidine and purine nucleotides. Here, we demonstrate that mTORC1 itself is s...
Main Authors: | Natasha Emmanuel, Shoba Ragunathan, Qin Shan, Fang Wang, Andreas Giannakou, Nanni Huser, Guixian Jin, Jeremy Myers, Robert T. Abraham, Keziban Unsal-Kacmaz |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221112471730685X |
Similar Items
-
Evaluation of the Binding Kinetics of RHEB with mTORC1 by In-Cell and In Vitro Assays
by: Raef Shams, et al.
Published: (2021-08-01) -
Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia
by: Yanan Gao, et al.
Published: (2016-04-01) -
Cardiac Ablation of Rheb1 Induces Impaired Heart Growth, Endoplasmic Reticulum-Associated Apoptosis and Heart Failure in Infant Mice
by: Yunshan Cao, et al.
Published: (2013-12-01) -
Current Models of Mammalian Target of Rapamycin Complex 1 (mTORC1) Activation by Growth Factors and Amino Acids
by: Xu Zheng, et al.
Published: (2014-11-01) -
Lysosomal Regulation of mTORC1 by Amino Acids in Mammalian Cells
by: Yao Yao, et al.
Published: (2017-07-01)